Eiger BioPharmaceuticals, Inc. (EIGR) has 38 open-market insider trades by 15 insiders since 2001. The most active filer is Thomas John Dietz, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Vivo Ventures Fund VI, L.P. | 10% Owner | — | 1 | $3.0M | 2016-08-18 |
| Gilbert H. Kliman | 10% Owner | — | 1 | $2.9M | 2018-10-18 |
| Jeffrey S. Glenn | Dir | — | 5 | $733K | 2022-12-22 |
| Thomas John Dietz | Dir | — | 9 | $397K | 2023-01-23 |
| Eldon C. Mayer III | VP | — | 7 | $358K | 2023-03-17 |
| James P. Shaffer | Chief Business Officer | — | 3 | $101K | 2021-03-12 |
| Richard A. Kayne | 10% | — | 1 | $73K | 2023-11-02 |
| James H. Welch | CFO | — | 1 | $49K | 2016-06-22 |
| Joanne Quan | Chief Medical Officer | — | 1 | $40K | 2018-04-02 |
| David A. Cory | Pres | — | 3 | $32K | 2022-03-11 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Leen Kawas | 10% | Buy | $6K | 2023-10-31 |
| Richard A. Kayne | 10% | Buy | $73K | 2023-10-31 |
| Eldon C. Mayer III | Ex VP & Chief Commerc. Officer | Sell | $5K | 2023-03-17 |
| Thomas John Dietz | Director | Buy | $72K | 2023-01-23 |
| Christine Murray | Director | Sell | $6K | 2022-12-29 |
| Jeffrey S. Glenn | Director | Buy | $128K | 2022-12-22 |
Companies that share insiders with EIGR, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Thomas John Dietz | Director | Sell | $26K | 2022-12-22 |
| David Apelian | Director | Sell | $49K | 2022-08-16 |
| Eldon C. Mayer III | Ex VP & Chief Commerc. Officer | Sell | $9K | 2022-03-14 |
| Sriram Ryali | CFO | Sell | $13K | 2022-03-14 |
| Eldon C. Mayer III | Ex VP & Chief Commerc. Officer | Sell | $8K | 2022-01-07 |
| Thomas John Dietz | Director | Buy | $21K | 2021-04-09 |
| Evan Loh | Director | Sell | $20K | 2021-03-15 |
| Eldon C. Mayer III | Ex VP & Chief Commerc. Officer | Sell | $20K | 2021-01-08 |
| Jeffrey S. Glenn | Director | Buy | $115K | 2020-08-11 |